Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of Non-Melanoma Skin Cancer: Radiologists Challenging and Risk Assessment.
Russo GM, Russo A, Urraro F, Cioce F, Gallo L, Belfiore MP, Sangiovanni A, Napolitano S, Troiani T, Verolino P, Sica A, Brancaccio G, Briatico G, Nardone V, Reginelli A. Russo GM, et al. Among authors: nardone v. Diagnostics (Basel). 2023 Feb 20;13(4):793. doi: 10.3390/diagnostics13040793. Diagnostics (Basel). 2023. PMID: 36832281 Free PMC article. Review.
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse.
Nardone V, Botta C, Caraglia M, Martino EC, Ambrosio MR, Carfagno T, Tini P, Semeraro L, Misso G, Grimaldi A, Boccellino M, Facchini G, Berretta M, Vischi G, Rocca BJ, Barone A, Tassone P, Tagliaferri P, Del Vecchio MT, Pirtoli L, Correale P. Nardone V, et al. Cancer Biol Ther. 2016 Nov;17(11):1213-1220. doi: 10.1080/15384047.2016.1235666. Cancer Biol Ther. 2016. PMID: 27791459 Free PMC article.
Combined epidermal growth factor receptor and Beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma.
Tini P, Belmonte G, Toscano M, Miracco C, Palumbo S, Pastina P, Battaglia G, Nardone V, Butorano MA, Masucci A, Cerase A, Pirtoli L. Tini P, et al. Among authors: nardone v. Biomed Res Int. 2015;2015:208076. doi: 10.1155/2015/208076. Epub 2015 Mar 3. Biomed Res Int. 2015. PMID: 25821789 Free PMC article.
Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study.
Roviello G, Petrioli R, Nardone V, Rosellini P, Multari AG, Conca R, Aieta M. Roviello G, et al. Among authors: nardone v. Medicine (Baltimore). 2018 May;97(20):e10745. doi: 10.1097/MD.0000000000010745. Medicine (Baltimore). 2018. PMID: 29768350 Free PMC article. Clinical Trial.
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?
Tini P, Nardone V, Pastina P, Marampon F, Sebaste L, Cerase A, Tombolini V, Pirtoli L, Mazzei MA. Tini P, et al. Among authors: nardone v. Clin Neurol Neurosurg. 2019 Sep;184:105445. doi: 10.1016/j.clineuro.2019.105445. Epub 2019 Jul 15. Clin Neurol Neurosurg. 2019. PMID: 31325903
130 results